Sheila M. Grant

Chief Tech/Sci/R&D Officer at XENON PHARMACEUTICALS INC.

Health Technology

Consumer Services

Profile

Sheila M.
Grant is currently the Executive VP-Research & Development Operations at Xenon Pharmaceuticals, Inc. Prior to her current position, she served as the Chief Operating Officer at Correvio Pharma Corp.
from 2013 to 2020.
Additionally, she worked as a Consultant at Twinstrand Therapeutics, Inc. Ms. Grant holds an MBA from Simon Fraser University, a graduate degree from the London School of Hygiene & Tropical Medicine, and an undergraduate degree from the University of Essex.

Sheila M. Grant active positions

Companies	Position	Start
XENON PHARMACEUTICALS INC.	Chief Tech/Sci/R&D Officer	2020-07-31

All active positions of Sheila M. Grant

Former positions of Sheila M. Grant

Companies	Position	End
CORREVIO PHARMA CORP.	Chief Operating Officer	2020-05-26
Twinstrand Therapeutics, Inc. Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.	Corporate Officer/Principal	-

See the detail of Sheila M. Grant's experience

Training of Sheila M. Grant

Simon Fraser University	Masters Business Admin
London School of Hygiene & Tropical Medicine	Graduate Degree
University of Essex	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Sheila M. Grant's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
XENON PHARMACEUTICALS INC.	Health Technology

Private companies	2
Correvio Pharma Corp. Correvio Pharma Corp. Pharmaceuticals: MajorHealth Technology Correvio Pharma Corp. operates as a pharmaceutical company, which engages in the provision of development and commercialization of medical products. It operates through the Europe and Rest of the World geographical segments. The firm focuses on cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease. It offers the Brinavess and Aggrastat products to customers such as physicians, patients and healthcare systems. The company was founded in 1986 and is headquartered in Vancouver, Canada.	Health Technology
Twinstrand Therapeutics, Inc. Twinstrand Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.	Health Technology